My Story – Danny Welch, PhD
Danny Welch, PhD, joined the University of Kansas Cancer Center in April 2011 as associate director of Basic Science. He serves as the founding director of the Department of Cancer Biology and director for National Foundation for Cancer Research Center for Metastasis Research for The University of Kansas Medical Center, chair and professor of Cancer Biology at The University of Kansas School of Medicine and is a Kansas Bioscience Authority Eminent Scholar.
“Dr. Welch is an outstanding scientist with superb administrative credentials and we are fortunate to have him join KU in this leadership role,” said Paul Terranova, PhD, vice chancellor for research at The University of Kansas Medical Center. “The new Department of Cancer Biology supports the interdisciplinary and collegial atmosphere within the cancer center with a focus on faculty research and training, and mentoring of student scholars.”
The focus of Dr. Welch’s research is on the science of tumor progression and the regulation of cancer metastasis. His lab has developed and characterized many widely used metastasis models, discovering six of the 30 known metastasis suppressors. With experience in genetics, biochemistry, molecular biology and cell biology, his research interests includes breast, melanoma, ovarian, pancreatic, colorectal, glioblastoma and lymphoma.
“One of the enticing things about The University of Kansas Cancer Center is the opportunity to contribute in a significant way,” said Dr. Welch. “We are excited to work toward translating some of these metastasis suppressor genes for patient use as part of their treatment regime for multiple types of cancer.”
Dr. Welch currently serves on the board of directors for the Cancer Biology Training Consortium and on the Extramural Scientific Advisory Board for the American Cancer Society. He is past president of the Metastasis Research Society, past chair of the National Institutes of Health/National Cancer Institute Cancer Genetics Study Section and has been actively involved with the American Association of Cancer Research (AACR). In 2010, he served on the Susan G. Komen International Scientific Advisory Board and his laboratory at The University of Kansas Cancer Center currently receives funding from the Susan G. Komen Foundation.
Dr. Welch received his PhD in Biomedical Sciences – Tumor Biology from The University of Texas – Houston Graduate School of Biomedical Sciences in 1984 and completed a post doctoral fellowship in Tumor Biology at The University of Texas – MD Anderson Cancer Center. From 2002 to 2010, he was the Leonard H. Robinson professor of pathology at the University of Alabama at Birmingham.